Form 8-K - Current report:
SEC Accession No. 0001193125-25-184093
Filing Date
2025-08-20
Accepted
2025-08-20 16:16:08
Documents
23
Period of Report
2025-08-18
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d929636d8k.htm   iXBRL 8-K 51496
2 EX-1.1 d929636dex11.htm EX-1.1 340195
3 EX-4.3 d929636dex43.htm EX-4.3 221797
4 EX-4.4 d929636dex44.htm EX-4.4 98419
5 EX-5.1 d929636dex51.htm EX-5.1 15597
6 EX-5.2 d929636dex52.htm EX-5.2 12003
11 GRAPHIC g929636dsp094.jpg GRAPHIC 3295
12 GRAPHIC g929636dsp095.jpg GRAPHIC 2820
13 GRAPHIC g929636dsp097.jpg GRAPHIC 2429
14 GRAPHIC g929636g0819131914885.jpg GRAPHIC 2678
15 GRAPHIC g929636g0819131915231.jpg GRAPHIC 3309
  Complete submission text file 0001193125-25-184093.txt   1118905

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA lly-20250818.xsd EX-101.SCH 5720
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE lly-20250818_def.xml EX-101.DEF 16100
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE lly-20250818_lab.xml EX-101.LAB 27714
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE lly-20250818_pre.xml EX-101.PRE 17522
26 EXTRACTED XBRL INSTANCE DOCUMENT d929636d8k_htm.xml XML 14726
Mailing Address LILLY CORPORATE CENTER DROP CODE 1094 INDIANAPOLIS IN 46285
Business Address LILLY CORPORATE CTR DROP CODE 1094 INDIANAPOLIS IN 46285 3172762000
ELI LILLY & Co (Filer) CIK: 0000059478 (see all company filings)

EIN.: 350470950 | State of Incorp.: IN | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-06351 | Film No.: 251236962
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)